Emergent-Valneva Zika vaccine clears early trial

A vaccine to prevent infections caused by the deadly mosquito-borne Zika virus induced immune response and was found to be safe in an early stage trial, Emergent BioSolutions Inc and partner Valneva SE said on Monday.

from Reuters: Health https://ift.tt/2QXVP7a
via IFTTT

• Tweet
• Share
• Share
• Share
• Share